Teva Pharmaceutical Industries Common Stock Net 2010-2025 | TEVA

Teva Pharmaceutical Industries common stock net for the quarter ending March 31, 2025 was $0.058B, a 0% increase year-over-year.

  • Teva Pharmaceutical Industries common stock net for 2024 was $0.058B, a 1.75% increase from 2023.
  • Teva Pharmaceutical Industries common stock net for 2023 was $0.057B, a 0% decline from 2022.
  • Teva Pharmaceutical Industries common stock net for 2022 was $0.057B, a 0% decline from 2021.

Teva Pharmaceutical Industries Common Stock Net 2010-2025 | TEVA

  • Teva Pharmaceutical Industries common stock net for 2024 was $0.058B, a 1.75% increase from 2023.
  • Teva Pharmaceutical Industries common stock net for 2023 was $0.057B, a 0% decline from 2022.
  • Teva Pharmaceutical Industries common stock net for 2022 was $0.057B, a 0% decline from 2021.
Related Stocks
Company NameMarket
Cap
Dr Reddy's Laboratories (RDY)$11.4B
BridgeBio Pharma (BBIO)$6.4B
Bausch Health Cos (BHC)$1.9B
Supernus Pharmaceuticals (SUPN)$1.7B
Amphastar Pharmaceuticals (AMPH)$1.1B
Personalis (PSNL)$282M
Taysha Gene Therapies (TSHA)$254M
Assembly Biosciences (ASMB)$75M
Sol-Gel Technologies (SLGL)$15M
Evoke Pharma (EVOK)$3M
Teligent (TLGT)$0M